The U.S. Supreme Court on June 21 declined to hear a bid by health insurance companies to seek a full reimbursement from the federal government under a provision of the Obamacare law aimed at encouraging them to offer medical coverage to uninsured Americans.

The U.S. Supreme Court on June 21 declined to hear AbbVie Inc.’s challenge to a lower court’s decision that the company violated federal antitrust law by pursuing a “sham” patent complaint against rival Perrigo Co. over AbbVie’s blockbuster testosterone replacement drug AndroGel.

The U.S. Supreme Court on June 21 rejected a bid by an Amarin Corp. subsidiary to revive patents on the company’s heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals Plc and Dr. Reddy’s Laboratories Ltd.

The U.S. Supreme Court on June 1 declined to hear Johnson & Johnson’s bid to overturn a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in the company’s baby powder and other talc products.

The U.S. Supreme Court on May 17 dashed Novartis AG’s hopes of launching a generic version of Amgen Inc.’s multibillion-dollar rheumatoid arthritis medicine Enbrel, declining to hear the company’s challenge to two patents on the drug.

The U.S. Supreme Court rejected a bid by Johnson & Johnson to overturn a $70 million jury verdict against the pharmaceutical company for J&J’s failure to warn about risks associated with off-label uses of the antipsychotic drug Risperdal.

Brazil on April 8 set a daily record of 4,249 Covid-19 deaths, with overwhelmed hospitals running low on supplies and the Senate about to open an investigation into the response of the government of President Jair Bolsonaro, who has played down the pandemic from the start.

The U.S. Supreme Court rejected Merck & Co. Inc.’s bid to revive a $2.54 billion jury verdict the company won against rival drugmaker Gilead Sciences Inc. for infringing a patent in a dispute over a blockbuster hepatitis C treatment.

The U.S. Supreme Court agreed to hear a bid by President Donald Trump’s administration to revive pilot programs adopted by the states of Arkansas and New Hampshire that allow work requirements to be imposed on people who receive healthcare under the Medicaid program for the poor.

U.S. health authorities will hold an emergency meeting to recommend that a coronavirus vaccine awaiting approval be given first to healthcare professionals and people in long-term care facilities.